巨病和COVID-19,教训和新的机会
Elena V Varlamov1,2,3, Maria Fleseriu4,5,6
1Pituitary Center, Oregon Health & Science University, Portland, OR, 97239, USA.
Pituitary
|May 31, 2024
概括
随着COVID-19的流行,壮症患者的护理受到了影响,远程医疗的使用增加,并且需要手术安全协议. 虽然没有报道了巨患者的负面COVID-19结果,但他们的心理健康可能会受到影响.
科学领域:
- 内分泌学 在内分泌学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- COVID-19大流行严重扰乱了医疗保健的提供,包括管理内分泌疾病,如壮症.
- 巨症患者可能面临由于并发症而增加的风险,可能会使COVID-19的结果恶化.
- 在壮病患者中,先前存在的心理健康挑战可能会因疫情而恶化.
研究的目的:
- 评估在COVID-19大流行期间管理壮病患者的挑战和适应方式.
- 评估大流行病对巨病诊断,治疗和患者结局的影响.
- 为了探索在患有并发症的壮病患者中可能增加严重COVID-19的潜在风险.
主要方法:
- 审查疫情期间的临床管理策略和患者护理中断.
- 对远程医疗的采用和对 pituitary 手术的外科手术方案的实施进行分析.
- 检查壮病并发症及其对COVID-19严重程度的潜在影响.
主要成果:
- 远程医疗促进了持续护理,克服了面对面的限制.
- 手术安全协议和广泛的测试使得下垂体手术的恢复成为可能.
- 尽管存在潜在的并发症风险,但在壮病患者中没有观察到COVID-19结果的不良趋势.
结论:
- 疫情需要适应性策略,包括远程医疗和增强的安全协议,用于壮病管理.
- 患有并发症的壮病患者需要对严重的COVID-19进行仔细监测,尽管目前的数据显示没有增加的风险.
- 进一步的研究至关重要,以了解大流行对壮病患者发病率,死亡率和神经心理健康的长期影响.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Cystic Fibrosis: Management
154
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
154
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
Pleural Effusion II: Symptoms and Management
165
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
165
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Overview of Carbohydrate Metabolism
913
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
913


